HORMONES N – Z
Nestler, J E, Barlascini, CO, Clore, JN & Blackard WG, 1988, ‘Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men’, Journal of Clinical Endocrinology & Metabolism, vol 66(1), Pages 57-61.
Osseni, RA, Rat, P, Bogdan, A, Warnet, J & Touitou, Y, 2001, ‘Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2’, Life Sciences, 502 Pages 127-131.
Pappolla M, Bozner, P, Soto, C, Shao, H, Robakis, N, Zagorski, M, Frangione, B & Ghiso, J, 1998 , ‘Inhibition of Alzheimer -Fibrillogenesis by Melatonin’, Journal of Biological Chemistry, vol 273, issue 13, Pages 7185-7188.
Petrie, K, Dawson, AG, Thompson L & Brook R, 1993, ‘A double-blind trial of melatonin as a treatment for jet lag in international cabin crew’, Biological Psychiatry, vol 33, Pages 526-530.
Pieri, C, Maurizio M, Moroni F, Recchioni R & Marcheselli F, 1994, ‘Melatonin: a peroxyl radical scavenger more effective than vitamin E’, Life Sciences: Pharmacology Letters, vol 55, no 15, Page 271-276.
Pierpaoli, W, Bulian, D, Bulian, G & Kistler, G, 1999, Thyrotropin-Releasing Hormone Accelerates and Enhances the Age-Postponing Effects of Melatonin’, Journal of Anti-Aging Medicine, Winter, Pages 343-348.
Pierpaoli, W & Regelson, W, 1994, ‘Pineal control of aging: effect of melatonin and pineal grafting on aging mice’, Proceedings of the National Academy of Sciences, vol 91, no 2, Pages 787-791.
Qi, W, Reiter, RJ, Tan, DX, Garcia, J, Manchester, L, Karbownik, M & Calvo, J, 2000, ‘Chromium(III)-Induced 8-Hydroxydeoxyguanosine in DNA and Its Reduction by Antioxidants: Comparative Effects of Melatonin, Ascorbate, and Vitamin E’, Environmental Health Perspectives, vol, 108, no 5, Pages 399-402.
Rao, GN, Ney E & Herbert, RA, 2000, ‘Effect of Melatonin and Linolenic Acid on Mammary Cancer in Transgenic Mice with c-neu Breast Cancer Oncogene’, Breast Cancer Research and Treatment, vol, 64, no 3, Pages 287-296.
Reiter, WJ, Pycha, A, Schatzl G, et al. 1999 ‘Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind randomized, placebo-controlled study’, Urology, vol 53, Pages 590-595.
Reiter, RJ & Tan, DX, 2003, ‘Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart’, Cardiovascular Research, vol 58, no 1, Pages 10-19.
Reiter, RJ, Tan, DX, Leon, J, Kilic, U & Kilic, E, 2005, ‘When Melatonin Gets on Your Nerves: Its Beneficial Actions in Experimental Models of Stroke’, Experimental Biology and Medicine, vol 230, no 2, Pages 104-117.
Rudman, D, Feller, AG, Nagraj, HS, Gergans, GA, Lalitha, PY, Goldberg, AF, Schlenker, RA , Cohn, L , Rudman, IW & Mattson DE, 1990, ‘Effects of human growth hormone in men over 60 years old’, The New England Journal of Medicine, vol 323, Pages 1-6.
Sanchez-Barcelo, EJ, Cos, S, Fernandez, R & Mediavilla, MD, 2003, ‘Melatonin and mammary cancer: a short review’, Endocrine-Related Cancer, vol 10, issue 2, Pages 153-159.
Serrata, MA, Vinyard, CJ & King, D, 2007, ‘Alterations in the mechanical properties and composition of skin in human growth hormone transgenic mice’, Connective Tissue Research, vol 48, issue 1, Pages 19-26.
Wolkowitz, OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, & Roberts E, 1999, ‘Double-blind treatment of major depression with dehydroepiandrosterone’, The American Journal of Psychiatry, vol 156, Pages 646–649.
Yen SS, Morales AJ & Khorram, O, 1995, ‘Replacement of DHEA in aging men and women’, Annals of the New York Academy of Sciences, vol 774, Pages 128-142.
Zhadanova, IV, Wurtman, RJ & Lynch, HJ, 1995, ‘Sleep inducing effects of low doses of melatonin ingested in the evening’, Clinical Pharmacology & Therapeutics, vol 57, Pages 552-558.
